Wednesday, April 2, 2025
ENGLISH

Daily Reads

‘Translation Error’ Behind Misinformation On Afghanistan Cannabis Processing Unit

Written By Pankaj Menon
Nov 26, 2021
banner_image

A day after Afghanistan Interior Ministry took to twitter to announced a $450 mn investment by an Australian company Cpharm to set up a hashish (Cannabis) processing unit in the Taliban ruled country, the company at the centre of the news has called out the claim as false, and clarified that they have no connection with Taliban or Afghanistan. But there is more to it than mere false claim by the Afghan Interior Ministry.

Several international media including BBC and Al Arabiya reported that the Afghanistan government was teaming up with an Australian company Cpharm.

The reports emerged after tweet by the Afghan Interior Ministry Spokesperson Saeed Khosty.

In his the tweets, Khosty claims that Cpharm would cultivate cannabis on in “30 acres of land and would invest $ 450 million in this sector. It is worth mentioning that all stages of the contract with the mentioned company have been completed and this project will officially start in the coming days.”

A tweet thread from the handle of the Interior ministry of Afghanistan also referred to the same ‘deal’. “Medicines and creams would be manufactured by the hashish-processing factory. The project will be officially launched soon and hundreds of people will get job opportunities on the project,” the ministry said. 

But curiously, neither Khosty nor the Afghan MOI handle claimed that the company is from Australia. The claim seems to have originated from a Pajhwok News report, which linked the ‘Cpharm company’ in the tweets to the Australian company Cpharm.

Article on Australian company Cpharm
A screengrab of the article that was published in Pajhwok

Soon enough, the Australian company, in a statement to Reuters, clarified that the news was not true and that they were not associated with the developments. 

Taking note of the various reports in international press and the Taliban’s tweets, the Australian company Cpharm also issued a statement denying the claim in their website.

The Australian company Cpharm, which calls itself a ‘boutique company’ on its  website, said in a statement, “We DO NOT manufacture or supply anything. We provide a medical advice service to the pharmaceutical industry within Australia. We have no products on the ARTG. We have no connection with cannabis or the Taliban. We have no idea where the Taliban media release has come from and want to assure everyone that it should not be connected to Cpharm Pty Ltd Australia.”

Newschecker reached out to Pahjhwok News to enquire the source of the claim that the company was Australian. Ahmad Shah Erfanyar, whose name is featured on the article, responded, “The story was written in our native language Pashto, and in Pashto, the company was a German firm, not Australian. The error occured during translation from Pashto to English. The company is German and not Australian.”


If you would like us to fact check a claim, give feedback or lodge a complaint, WhatsApp us at 9999499044 or email us at checkthis@newschecker.in. You can also visit the Contact Us page and fill the form.

image
If you would like us to fact check a claim, give feedback or lodge a complaint WhatsApp us at +91-9999499044 or email us at checkthis@newschecker.in​. You can also visit the Contact Us​ page and fill the form.
Newchecker footer logo
Newchecker footer logo
Newchecker footer logo
Newchecker footer logo
About Us

Newchecker.in is an independent fact-checking initiative of NC Media Networks Pvt. Ltd. We welcome our readers to send us claims to fact check. If you believe a story or statement deserves a fact check, or an error has been made with a published fact check

Contact Us: checkthis@newschecker.in

17,631

Fact checks done

FOLLOW US
imageimageimageimageimageimageimage
Copyright © 2022 NC Media Pvt. Ltd. All Rights Reserved.
cookie

Our website uses Cookies

We use cookies and similar technologies to help personalise content,tailor and measure ads, and provide a better experience. By clicking OK or turning an option on in Cookie Preferences, you agree to this, as outlined in our Cookie Policy.